Tyrosine kinase inhibitors alter adhesivity of prostatic cancer cells to extracellular matrix components

APMIS

Volumn 114, Issue 3, 2006, Pages 225-233

  Skogseth, Haakon ^a   Holt, Randi Utne ^a   Larsson, Erik ^a   Halgunset, Jostein ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

AG 1478; DU 145; Genistein; Integrin; PC 3

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; GENISTEIN; LAMININ; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR; VITRONECTIN;

ARTICLE; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENISTEIN; HUMANS; INTEGRINS; MALE; PROSTATIC NEOPLASMS; PROTEIN KINASE INHIBITORS; TYRPHOSTINS;

EID: 33646110766     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_365.x     Document Type: Article

References (26)

1. Andreasen PA Egelund R Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000 57 25 40.
2. Price J Bonovich M Kohn E. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997 32 175 253.
3. Danen EH. Integrins: regulators of tissue function and cancer progression. Curr Pharm Des 2005 11 881 91.
4. Pinski J Dorff TB. Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy. Eur J Cancer 2005 41 932 40.
5. Fornaro M Manes T Languino LR. Integrins and prostate cancer metastasis. Cancer Metastasis Rev 2001 20 321 31.
6. Festuccia C Bologna M Gravina GL Guerra F Angelucci A Villanova I Millimaggi D Teti A. Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 1999 81 395 403.
7. Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992 69 11 25.
8. Rokhlin OW Cohen MB. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate 1995 26 205 12.
9. Yebra M Goretzki L Pfeifer M Mueller BM. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res 1999 250 231 40.
10. Skogseth H Larsson E Halgunset J. Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells. APMIS 2005 113 332 9.
11. Kaighn ME Narayan KS Ohnuki Y Lechner JF Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979 17 16 23.
12. Stone KR Mickey DD Wunderli H Mickey GH Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978 15 274 81.
13. Akiyama T Ishida J Nakagawa S Ogawara H Watanabe S Itoh N Shibuya M Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987 262 5592 5.
14. Ward WH Cook PN Slater AM Davies DH Holdgate GA Green LR. Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure based searching and discovery of a potent inhibitor. Biochem Pharmacol 1994 17 659 66.
15. Bergan R Kyle E Nguyen P Trepel J Ingui C Neckers L. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin Exp Metastasis 1996 14 389 98.
16. Mirtti T Nylund C Lehtonen J Hiekkanen H Nissinen L Kallajoki M Alanen K Gullberg D Heino J. Regulation of prostate cell collagen receptors by malignant transformation. Int J Cancer 2005 ahead of print
17. Schmelz M Cress AE Scott KM Burger F Cui H Sallam K McDaniel KM Dalkin BL Nagle RB. Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia 2002 4 243 54.
18. Evangelou A Letarte M Marks A Brown TJ. Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor. Endocrinology 2002 143 3897 904.
19. Nagakawa O. Differential expression of integrin subunits in DU-145/AR prostate cancer cells. Oncol Rep 2004 12 837 41.
20. Li R Wheeler T Dai H Frolov A Thompson T Ayala G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 2004 28 928 34.
21. Amirghofran Z Monabati A Gholijani N. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer. Pathol Oncol Res 2004 10 37 41.
22. Jewell K Kapron-Bras C Jeevaratnam P Dedhar S. Stimulation of tyrosine phosphorylation of distinct proteins in response to antibody-mediated ligation and clustering of alpha 3 and alpha 6 integrins. J Cell Sci 1995 108 1165 74.
23. Cooper CR McLean L Walsh M Taylor J Hayasaka S Bhatia J Pienta KJ. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin Cancer Res 2000 6 4839 47.
24. Cooper CR McLean L Mucci NR Poncza P Pienta KJ. Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by beta-1 integrin subunit. Anticancer Res 2000 20 4159 62.
25. Scott LJ Clarke NW George NJ Shanks JH Testa NG Lang SH. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 2001 84 1417 23.
26. Festuccia C Bologna M Gravina GL Guerra F Angelucci A Villanova I Millimaggi D Teti A. Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 1999 81 395 403.